GSK‐3β Cancer Research Results

GSK‐3β, Glycogen synthase kinase (GSK)3β: Click to Expand ⟱
Source:
Type:
GSK3β is a crucial member of the Wnt/β-catenin-, hedgehog (Hh)-, notch- and c-myc-mediated major pro-oncogenic pathways, while also being a negative regulator of epithelial–mesenchymal transition (EMT). Accumulating evidence defines GSK3β as a potential therapeutic target in cancer, thus encouraging the development of GSK3β inhibitors for cancer treatment.
Glycogen synthase kinase 3 beta (GSK-3β) is a serine/threonine kinase that plays a crucial role in various cellular processes, including cell proliferation, differentiation, and apoptosis. Its expression and activity have been implicated in several types of cancer, often with varying prognostic implications.

In many cancers, decreased GSK-3β activity is associated with poor prognosis, while in others, increased activity may correlate with aggressive disease.


Scientific Papers found: Click to Expand⟱
2119- TQ,    Dual properties of Nigella Sativa: anti-oxidant and pro-oxidant
- Review, Var, NA
*ROS↓, ROS↑, chemoP↑, RenoP↑, hepatoP↑, NLRP3↓, neuroP↑, NF-kB↓, P21↑, HDAC↓, Apoptosis↑, TumCP↓, GSH↓, GADD45A↑, GSK‐3β↑,
2106- TQ,    Cancer: Thymoquinone antioxidant/pro-oxidant effect as potential anticancer remedy
- Review, Var, NA
Apoptosis↑, TumCCA↑, ROS↑, *Catalase↑, *SOD↑, *GR↑, *GSTA1↓, *GPx↑, *H2O2↓, *ROS↓, *lipid-P↓, *HO-1↑, p‑Akt↓, AMPKα↑, NK cell↑, selectivity↑, Dose↝, eff↑, GSH↓, eff↓, P53↑, p‑STAT3↓, PI3K↑, MAPK↑, GSK‐3β↑, ChemoSen↑, RadioS↑, BioAv↓, NRF2↑,
3407- TQ,    Thymoquinone and its pharmacological perspective: A review
- Review, NA, NA
*antiOx↑, *ROS↓, *GSTs↑, *GSR↑, *GSH↑, *RenoP↑, *IL1β↓, *TNF-α↓, *MMP13↓, *COX2↓, *PGE2↓, *radioP↑, Twist↓, EMT↓, NF-kB↓, p‑PI3K↓, p‑Akt↓, p‑GSK‐3β↓, DNMT1↓, HDAC↓,
3397- TQ,    Thymoquinone: A Promising Therapeutic Agent for the Treatment of Colorectal Cancer
- Review, CRC, NA
ChemoSen↑, *Half-Life↝, *BioAv↝, *antiOx↑, *Inflam↓, *hepatoP↑, TumCP↓, TumCCA↑, Apoptosis↑, angioG↑, selectivity↑, JNK↑, p38↑, p‑NF-kB↑, ERK↓, PI3K↓, PTEN↑, Akt↓, mTOR↓, EMT↓, Twist↓, E-cadherin↓, ROS⇅, *Catalase↑, *SOD↑, *GSTA1↑, *GPx↑, *PGE2↓, *IL1β↓, *COX2↓, *MMP13↓, MMPs↓, TumMeta↓, VEGF↓, STAT3↓, BAX↑, Bcl-2↑, Casp9↑, Casp7↑, Casp3↑, cl‑PARP↑, survivin↓, cMyc↓, cycD1/CCND1↓, p27↑, P21↑, GSK‐3β↓, β-catenin/ZEB1↓, chemoP↑,
3427- TQ,    Chemopreventive and Anticancer Effects of Thymoquinone: Cellular and Molecular Targets
ROS⇅, Fas↑, DR5↑, TRAIL↑, Casp3↑, Casp8↑, Casp9↑, P53↑, mTOR↓, Bcl-2↓, BID↓, CXCR4↓, JNK↑, p38↑, MAPK↑, LC3II↑, ATG7↑, Beclin-1↑, AMPK↑, PPARγ↑, eIF2α↓, P70S6K↓, VEGF↓, ERK↓, NF-kB↓, XIAP↓, survivin↓, p65↓, DLC1↑, FOXO↑, TET2↑, CYP1B1↑, UHRF1↓, DNMT1↓, HDAC1↓, IL2↑, IL1↓, IL6↓, IL10↓, IL12↓, TNF-α↓, iNOS↓, COX2↓, 5LO↓, AP-1↓, PI3K↓, Akt↓, cMET↓, VEGFR2/KDR/Flk1↓, CXCL1↓, ITGA5↓, Wnt↓, β-catenin/ZEB1↓, GSK‐3β↓, Myc↓, cycD1/CCND1↓, N-cadherin↓, Snail↓, Slug↓, Vim↓, Twist↓, Zeb1↓, MMP2↓, MMP7↓, MMP9↓, JAK2↓, STAT3↓, NOTCH↓, cycA1/CCNA1↓, CDK2↓, CDK4↓, CDK6↓, CDC2↓, CDC25↓, Mcl-1↓, E2Fs↓, p16↑, p27↑, P21↑, ChemoSen↑,
4311- VitB1/Thiamine,    Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy
- in-vivo, AD, NA
*Aβ↓, *p‑tau↓, *ROS↓, *cognitive↑, *OS↑, *Mood↑, *neuroP↑, *Inflam↓, *NRF2↑, *PGC-1α↑, *AGEs↓, *4-HNE↓, *NQO1↑, *COX2↓, *TNF-α↓, *IL1β↓, *NF-kB↓, *GSK‐3β↓,

Showing Research Papers: 101 to 106 of 106
Prev Page 3 of 3

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 106

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress(tgid=1)

GSH↓, 2,   NRF2↑, 1,   ROS↑, 2,   ROS⇅, 2,  

Mitochondria & Bioenergetics(tgid=3)

CDC2↓, 1,   CDC25↓, 1,   XIAP↓, 1,  

Core Metabolism/Glycolysis(tgid=4)

AMPK↑, 1,   ATG7↑, 1,   cMyc↓, 1,   PPARγ↑, 1,  

Cell Death(tgid=5)

Akt↓, 2,   p‑Akt↓, 2,   Apoptosis↑, 3,   BAX↑, 1,   Bcl-2↓, 1,   Bcl-2↑, 1,   BID↓, 1,   Casp3↑, 2,   Casp7↑, 1,   Casp8↑, 1,   Casp9↑, 2,   DR5↑, 1,   Fas↑, 1,   iNOS↓, 1,   JNK↑, 2,   MAPK↑, 2,   Mcl-1↓, 1,   Myc↓, 1,   p27↑, 2,   p38↑, 2,   survivin↓, 2,   TRAIL↑, 1,  

Kinase & Signal Transduction(tgid=6)

AMPKα↑, 1,  

Protein Folding & ER Stress(tgid=8)

eIF2α↓, 1,  

Autophagy & Lysosomes(tgid=9)

Beclin-1↑, 1,   LC3II↑, 1,  

DNA Damage & Repair(tgid=10)

CYP1B1↑, 1,   DNMT1↓, 2,   GADD45A↑, 1,   p16↑, 1,   P53↑, 2,   cl‑PARP↑, 1,   UHRF1↓, 1,  

Cell Cycle & Senescence(tgid=11)

CDK2↓, 1,   CDK4↓, 1,   cycA1/CCNA1↓, 1,   cycD1/CCND1↓, 2,   E2Fs↓, 1,   P21↑, 3,   TumCCA↑, 2,  

Proliferation, Differentiation & Cell State(tgid=12)

cMET↓, 1,   EMT↓, 2,   ERK↓, 2,   FOXO↑, 1,   GSK‐3β↓, 2,   GSK‐3β↑, 2,   p‑GSK‐3β↓, 1,   HDAC↓, 2,   HDAC1↓, 1,   mTOR↓, 2,   NOTCH↓, 1,   P70S6K↓, 1,   PI3K↓, 2,   PI3K↑, 1,   p‑PI3K↓, 1,   PTEN↑, 1,   STAT3↓, 2,   p‑STAT3↓, 1,   Wnt↓, 1,  

Migration(tgid=13)

5LO↓, 1,   AP-1↓, 1,   DLC1↑, 1,   E-cadherin↓, 1,   ITGA5↓, 1,   MMP2↓, 1,   MMP7↓, 1,   MMP9↓, 1,   MMPs↓, 1,   N-cadherin↓, 1,   Slug↓, 1,   Snail↓, 1,   TumCP↓, 2,   TumMeta↓, 1,   Twist↓, 3,   Vim↓, 1,   Zeb1↓, 1,   β-catenin/ZEB1↓, 2,  

Angiogenesis & Vasculature(tgid=14)

angioG↑, 1,   VEGF↓, 2,   VEGFR2/KDR/Flk1↓, 1,  

Immune & Inflammatory Signaling(tgid=16)

COX2↓, 1,   CXCL1↓, 1,   CXCR4↓, 1,   IL1↓, 1,   IL10↓, 1,   IL12↓, 1,   IL2↑, 1,   IL6↓, 1,   JAK2↓, 1,   NF-kB↓, 3,   p‑NF-kB↑, 1,   NK cell↑, 1,   p65↓, 1,   TNF-α↓, 1,  

Protein Aggregation(tgid=19)

NLRP3↓, 1,  

Hormonal & Nuclear Receptors(tgid=20)

CDK6↓, 1,  

Drug Metabolism & Resistance(tgid=21)

BioAv↓, 1,   ChemoSen↑, 3,   Dose↝, 1,   eff↓, 1,   eff↑, 1,   RadioS↑, 1,   selectivity↑, 2,   TET2↑, 1,  

Clinical Biomarkers(tgid=22)

IL6↓, 1,   Myc↓, 1,  

Functional Outcomes(tgid=23)

chemoP↑, 2,   hepatoP↑, 1,   neuroP↑, 1,   RenoP↑, 1,  
Total Targets: 121

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress(tgid=1)

4-HNE↓, 1,   antiOx↑, 2,   Catalase↑, 2,   GPx↑, 2,   GSH↑, 1,   GSR↑, 1,   GSTA1↓, 1,   GSTA1↑, 1,   GSTs↑, 1,   H2O2↓, 1,   HO-1↑, 1,   lipid-P↓, 1,   NQO1↑, 1,   NRF2↑, 1,   ROS↓, 4,   SOD↑, 2,  

Mitochondria & Bioenergetics(tgid=3)

PGC-1α↑, 1,  

Proliferation, Differentiation & Cell State(tgid=12)

GSK‐3β↓, 1,  

Migration(tgid=13)

MMP13↓, 2,  

Immune & Inflammatory Signaling(tgid=16)

COX2↓, 3,   IL1β↓, 3,   Inflam↓, 2,   NF-kB↓, 1,   PGE2↓, 2,   TNF-α↓, 2,  

Synaptic & Neurotransmission(tgid=18)

p‑tau↓, 1,  

Protein Aggregation(tgid=19)

AGEs↓, 1,   Aβ↓, 1,  

Hormonal & Nuclear Receptors(tgid=20)

GR↑, 1,  

Drug Metabolism & Resistance(tgid=21)

BioAv↝, 1,   Half-Life↝, 1,  

Functional Outcomes(tgid=23)

cognitive↑, 1,   hepatoP↑, 1,   Mood↑, 1,   neuroP↑, 1,   OS↑, 1,   radioP↑, 1,   RenoP↑, 1,  
Total Targets: 38

Scientific Paper Hit Count for: GSK‐3β, Glycogen synthase kinase (GSK)3β
13 Curcumin
9 Resveratrol
6 Thymoquinone
5 Apigenin (mainly Parsley)
4 Luteolin
4 Quercetin
3 Baicalein
3 Formononetin
3 Magnetic Fields
3 Nimbolide
3 Propolis -bee glue
2 1,8-Cineole
2 Astragalus
2 Astaxanthin
2 Berberine
2 Bacopa monnieri
2 Chlorogenic acid
2 Chrysin
2 EGCG (Epigallocatechin Gallate)
2 Fisetin
2 Ginkgetin
2 Juglone
2 Lycopene
2 salinomycin
1 Alpha-Lipoic-Acid
1 5-fluorouracil
1 Biochanin A
1 Brucea javanica
1 Boswellia (frankincense)
1 Caffeic acid
1 Caffeic Acid Phenethyl Ester (CAPE)
1 Carvacrol
1 Cynanbungeigenin C (CBC) and D (CBD)
1 Centella asiatica / Gotu kola → asiaticoside
1 chaetocin
1 Cinnamon
1 Crocetin
1 Deguelin
1 diet FMD Fasting Mimicking Diet
1 Chemotherapy
1 Ginkgo biloba-EGb 761
1 Protocatechuic acid
1 Emodin
1 Hydroxycinnamic-acid
1 Honokiol
1 lambertianic acid
1 Naringin
1 Phenylbutyrate
1 Piperine
1 Piperlongumine
1 Plumbagin
1 Gold NanoParticles
1 Arctigenin
1 Rosmarinic acid
1 Selenium NanoParticles
1 Shikonin
1 Vitamin B1/Thiamine
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:385  State#:%  Dir#:%
wNotes=0 sortOrder:rid,rpid

 

Home Page